RHJA
Rice Hall James & Associates’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.4M | Sell |
669,806
-2,417
| -0.4% | -$52.1K | 0.78% | 38 |
|
|
2025
Q1 | $11.2M | Sell |
672,223
-9,314
| -1% | -$155K | 0.66% | 43 |
|
|
2024
Q4 | $12.5M | Sell |
681,537
-35,609
| -5% | -$653K | 0.69% | 44 |
|
|
2024
Q3 | $11M | Sell |
717,146
-25,789
| -3% | -$397K | 0.6% | 47 |
|
|
2024
Q2 | $12.1M | Buy |
742,935
+78,379
| +12% | +$1.27M | 0.72% | 40 |
|
|
2024
Q1 | $12.3M | Sell |
664,556
-28,296
| -4% | -$523K | 0.7% | 40 |
|
|
2023
Q4 | $21.7M | Sell |
692,852
-3,213
| -0.5% | -$101K | 1.26% | 19 |
|
|
2023
Q3 | $14.5M | Sell |
696,065
-190,388
| -21% | -$3.97M | 0.92% | 33 |
|
|
2023
Q2 | $21.2M | Sell |
886,453
-673
| -0.1% | -$16.1K | 1.2% | 19 |
|
|
2023
Q1 | $16.7M | Sell |
887,126
-70,562
| -7% | -$1.33M | 0.95% | 28 |
|
|
2022
Q4 | $15.2M | Buy |
957,688
+433,818
| +83% | +$6.91M | 0.87% | 35 |
|
|
2022
Q3 | $8.57M | Sell |
523,870
-19,658
| -4% | -$322K | 0.5% | 53 |
|
|
2022
Q2 | $7.66M | Buy |
543,528
+80,224
| +17% | +$1.13M | 0.37% | 65 |
|
|
2022
Q1 | $11.2M | Buy |
463,304
+2,253
| +0.5% | +$54.6K | 0.45% | 63 |
|
|
2021
Q4 | $10.8M | Sell |
461,051
-35,706
| -7% | -$833K | 0.38% | 63 |
|
|
2021
Q3 | $8.25M | Sell |
496,757
-16,125
| -3% | -$268K | 0.3% | 72 |
|
|
2021
Q2 | $12.5M | Sell |
512,882
-61,054
| -11% | -$1.49M | 0.44% | 61 |
|
|
2021
Q1 | $14.8M | Buy |
573,936
+299,777
| +109% | +$7.73M | 0.48% | 58 |
|
|
2020
Q4 | $14.7M | Sell |
274,159
-820
| -0.3% | -$43.8K | 0.52% | 55 |
|
|
2020
Q3 | $11.3M | Buy |
274,979
+83,021
| +43% | +$3.42M | 0.46% | 58 |
|
|
2020
Q2 | $9.3M | Sell |
191,958
-4,137
| -2% | -$201K | 0.4% | 67 |
|
|
2020
Q1 | $8.29M | Buy |
+196,095
| New | +$8.29M | 0.46% | 64 |
|